Biomarkers for early detection of breast cancer may complement population screening
approaches to enable earlier and more precise treatment. The blood proteome is an important …

G protein–coupled receptors (GPCRs) control critical cellular signaling pathways. Therapeutic
agents including anti-GPCR antibodies (Abs) are being developed to modulate GPCR …

Objective Current breast cancer risk prediction scores and algorithms can potentially be
further improved by including molecular markers. To this end, we studied the association of …

Background Self-sampling of dried blood spots (DBS) offers new routes to gather valuable
health-related information from the general population. Yet, the utility of using deep proteome …

Calmodulin (CaM) is a calcium sensor which binds and regulates a wide range of target-proteins.
This implicitly enables the concentration of calcium to influence many downstream …

Accessible risk predictors are crucial for improving the early detection and prognosis of breast
cancer. Blood samples are widely available and contain proteins that provide important …

Receptor activity-modifying proteins (RAMPs) can form complexes with G protein-coupled
receptors (GPCRs) and regulate their cellular trafficking and pharmacology. RAMP …

The blood proteome reflects homeostatic and dynamic cellular processes across human
organs. However, few blood proteomics studies of sufficient depth and size have been reported …

Self-sampled blood provided valuable information about the COVID-19 seroprevalence in
the general population. To enable an even deeper understanding of pathophysiological …

Breast cancer is the most common cancer and the largest cause of cancer-related deathsworldwide
for women. Risk prediction of breast cancer allows individualised andpreventative …